Market News & Trends
Arena Pharmaceuticals Receives $65 Million From Eisai
Arena Pharmaceuticals, Inc. recently announced that the Office of the Federal Register filed for public inspection the US Drug Enforcement Administration's (DEA) final rule placing…
Recipharm & Synthonics Join Forces to Promote Delivery Technology
Recipharm Pharmaceutical Development AB and Synthonics, Inc. recently announced the formation of a Joint Promotion Agreement. The contract, the first of its kind to be…
Andain Announces Innovative Organ-Targeted Drug Delivery Nanoparticles
Andain Inc. recently announced its innovative nanoparticles drug delivery technology. Andain completed the development of innovative lipid-based drug delivery nanoparticles capable of carrying hydrophilic and…
Actavis Buys Antibiotic Vaginal Gel for $55 Million
Actavis, Inc. and Valeant Pharmaceuticals International, Inc. recently announced that Actavis Specialty Brands has acquired worldwide rights to Valeant's Metronidazole 1.3% Vaginal Gel antibiotic development…
FORMA Therapeutics Strikes $200-Million Deal
FORMA Therapeutics Holdings, recently announced a strategic collaboration agreement with Celgene Corporation under which FORMA and Celgene will discover, develop, and commercialize drug candidates to…
Imugene Granted Patent for Novel Delivery Technology
Australian drug delivery technology company Imugene recently announced the acceptance of a key Chinese patent application for the company’s novel drug delivery technology Linguet (Patent…
PAREXEL International Acquires HERON Group
PAREXEL International Corporation recently announced it has acquired all of the outstanding equity securities of the HERON Group LTD, a life sciences consultancy that provides…
Pharma & Biotech Industries Headed Toward an Era of Reduced Profit Margins
In the face of reduced profit margins for the pharmaceutical and biotechnology sectors, an effective financial management strategy is central to maintain sustainable growth. New…
Revolutionary Autoinjector Pushes the Limits of High-Viscosity Drug Delivery
Oval Medical Technologies Ltd recently announced that a variety of 1100 cPs solutions (the thickness of motor oil) have been successfully delivered through a 25-G…
Metrics Offers New Proprietary Technology to Improve Taste, Stability & Deliver SR Characteristics
Metrics Inc. now offers proprietary technology to mask the taste of tablets. The company’s innovative Cleantaste technology enables polymer coating of individual drug crystals to…
BASF & PETRONAS to Invest $500 Million
BASF and PETRONAS Chemicals Group Berhad intend to invest $500 million in an integrated aroma ingredients project at their existing joint venture site BASF PETRONAS…
BIND Therapeutics & AstraZeneca Announce Lucrative Worldwide Agreement
BIND Therapeutics and AstraZeneca recently announced it has entered into a strategic collaboration to develop and commercialize an Accurin, a targeted and programmable cancer nanomedicine…
Elite Pharmaceuticals Secures $10 Million Funding
Elite Pharmaceuticals, Inc. recently announced it has entered into a $10 million common stock purchase agreement with Lincoln Park Capital Fund, LLC, a Chicago-based institutional…
FDA Gives Breakthrough Designation to Merck Drug
Merck recently announced the US Food and Drug Administration (FDA) has designated lambrolizumab (MK-3475) as a Breakthrough Therapy for the treatment of patients with advanced…
GSK & Avalon to Form Up to 10 Biotechs in San Diego
GlaxoSmithKline PLC recently announced it will partner with venture capitalists from San Diego in an unusual deal worth up to $495 million to start several…
Carticept Medical Wins 510(k) Clearance
Carticept Medical, Inc. recently announced it has received 510(k) clearance from the US FDA for its enhanced Navigator Delivery System (DS), the first and only…
FDA Makes Decision on Abuse-Deterrent Formulations of Oxycontin Drug Products
Grünenthal recently announced it is pleased with the US Food and Drug Administration's (FDA) recent decisions regarding abuse-deterrent formulations (ADF) and prescription opioids. In its…
mPhase Technologies to Pursue Licensing Opportunities for Delivery System
mPhase Technologies, Inc. recently announced that it is pursuing licensing opportunities for its Smart Drug Delivery System. mPhase recently filed a United States Letter Patent…
Starpharma Granted Lucrative Drug Delivery Patents
Starpharma Holdings Ltd recently announced it has been granted three new patents by the United States Patent and Trademark Office (USPTO), which strengthen and expand…
Xenon Exclusively Licenses Merck Compounds
Xenon recently announced that Merck, through an affiliate, has exercised its option to exclusively license small molecule compounds for a novel target for the potential…
